Travis Murdoch is the founder of Human Immunology Biosciences. Human Immunology Biosciences has raised $120M in total funding. Latest round: Series B.
Travis Murdoch, MD, is the CEO of Human Immunology Biosciences (HI-Bio), a clinical-stage biotechnology company focused on developing targeted therapies for severe immune-mediated diseases. He led the company's emergence from stealth with $120 million in financing and later oversaw HI-Bio's $1.8 billion acquisition by Biogen in 2024.
Full founder directory · Investor directory · Company funding database · Fundraising library